Akebia Therapeutics Inc. buy SVB Leerink LLC
Start price
28.04.25
/
50%
€2.08
Target price
28.04.26
€6.16
Performance (%)
-46.55%
Price
16.04.26
€1.25
Summary
This prediction is currently active. The BUY prediction by SVB_Leerink_LLC for Akebia Therapeutics Inc. is performing very badly with a performance of -46.55%. This prediction currently runs until 28.04.26. The prediction end date can be changed by SVB_Leerink_LLC at any time. SVB_Leerink_LLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Akebia Therapeutics Inc. | 4.504% | 4.504% |
| iShares Core DAX® | 3.593% | 3.931% |
| iShares Nasdaq 100 | 5.810% | 5.518% |
| iShares Nikkei 225® | 4.075% | 8.460% |
| iShares S&P 500 | 4.142% | 4.039% |
Comments by SVB_Leerink_LLC for this prediction
In the thread Akebia Therapeutics Inc. diskutieren
Akebia Therapeutics, Inc. (NASDAQ: AKBA) is now covered by analysts at Leerink Partners. They set an "outperform" rating and a $7.00 price target on the stock.
Ratings data for AKBA provided by MarketBeat